Observational Single-center Study of the Relationship Between Arterial Hypertension and Hypervolemia Defined by Self-measurement of Impedancemetry in Kidney Transplant Patients With Transplantation Less Than 6 Months Old
HTAôConnect
Monocentric Observational Study to Determine the Relationship Between Arterial Hypertension and Hypervolaemia, Defined by Self-measurement of Impedancemetry in Kidney Transplant Recipients Under 6 Months Old
1 other identifier
observational
150
1 country
1
Brief Summary
The working hypothesis is that hypertension during the first post-transplant trimester is partly explained by the patient's hypervolemia. The main objective of the single-center observational study "HTA ô Connect" is to study the relationship between hypertension and extracellular hyperhydration, thanks to repeated self-measurements of blood pressure and impedancemetry between the 30th and the 90th day post-transplant, in 150 incident kidney transplant patients from our department, the ITUN (Institute of Urology-Nephrology Transplantation). The study population involves 150 incident kidney transplant patients, presenting to the Nantes University Hospital Transplant Institute for 1 month (D30), and presenting with hypertension ≥ 140/90mmHg and not treated with a diuretic. Data collected at the patients' homes will be used to establish a relationship between blood pressure and extracellular water volume. The data collected will not be used to follow up patients who participated in the study in this first stage of exploration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 8, 2021
CompletedFirst Posted
Study publicly available on registry
September 10, 2021
CompletedStudy Start
First participant enrolled
October 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2026
ExpectedApril 17, 2026
April 1, 2026
4 years
June 8, 2021
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Correlation between Hypertension and extracellular hyperhydration
Hypertension will be assessed by measurement of blood pressure
Day 90
Correlation between Hypertension and extracellular hyperhydration
Extracellular hyperhydration will be measured by impedance measurement
Day 90
Secondary Outcomes (10)
hypertension measurement
For 3 month post-transplant
Impedance measurement
For 3 month post-transplant
Weight measurement
day 30
Weight measurement
Day 90
Weight measurement
3 days a week between the 30th and the 90th day after transplantation.
- +5 more secondary outcomes
Interventions
Measurement of systolic and diastolic blood pressure, impedancemetry, weight, creatinemia and Pro-BNP measurements At D30 and D90 Measurement of systolic and diastolic blood pressure, impedancemetry, weight, 3 times a week between D30 and D90 post-transplant,
Eligibility Criteria
The study population involves 150 incident kidney transplant patients, presenting to the Nantes University Hospital Transplant Institute for 1 month (D30), and presenting with hypertension ≥ 140/90mmHg recorded in the outpatient clinic at the Nantes University Hospital, according to the recommendations of the French Society of Arterial Hypertension (6) and not treated with a diuretic. There will be no emergency inclusion. Recently transplanted patients will come regularly, between 1 and 2 times per week, to the Nantes University Hospital during the first month. The study will be presented to them during this period and they will be included at the D30 (M1) consultation.
You may qualify if:
- Age ≥ 18 years
- Blood pressure ≥ 140/90mmHg on 3 occasions and according to the recommendations of the French Society of Hypertension (6) at the M1 consultation
- Patients 1 to 6 months post-kidney transplant
- Isolated kidney transplant patient
- BMI between 16 and 34 kg/cm2
- Not opposed to the research
You may not qualify if:
- History of non-renal transplantation
- Minors, adults under guardianship and protected persons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nantes University Hospital
Nantes, Loire-Atlantique, 44093, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claire GARANDEAU, PH
Nantes University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2021
First Posted
September 10, 2021
Study Start
October 14, 2021
Primary Completion
October 14, 2025
Study Completion (Estimated)
August 10, 2026
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share